1. LBA9_PRCetuximab versus cisplatin in patients with HPV-positive, low risk oropharyngeal cancer, receiving radical radiotherapy. (23rd October 2018) Authors: Mehanna, H; Kong, A; Hartley, A; Mistry, P; Dalby, M; Fulton-Lieuw, T; Robinson, M; Gray, A; Foran, B; Sen, M; O'Toole, L; Dyker, K; Al Booz, H; Moleron, R; Brennan, S; Aynsley, E; Chan, A; Srinivasan, D; Buter, J; Dunn, J Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗